Federated Hermes’s Yarrow Bioscience YARW Stock Holding History

Federated Hermes’s Portfolio YARW Stock Details YARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3	Closed	-$513	–	2222
2023 Q3	$513	Hold	3	–	–	﹤0.01%	2040
2023 Q2	$521	Hold	3	–	–	﹤0.01%	2055
2023 Q1	$391	Hold	3	–	–	﹤0.01%	2087
2022 Q4	$344	Hold	3	–	–	﹤0.01%	2107
2022 Q3	$1K	Hold	3	–	–	﹤0.01%	2087
2022 Q2	$1K	Hold	3	–	–	﹤0.01%	2091
2022 Q1	$1K	Hold	3	–	–	﹤0.01%	2125
2021 Q4	$2K	Hold	3	–	–	﹤0.01%	2069
2021 Q3	$3K	Buy	+3	New	+$5.82K	﹤0.01%	2075
2019 Q2	–	Hold	0	–	-$4K	–	2228
2019 Q1	–	Hold	0	–	–	–	2009
2018 Q4	–	Hold	0	–	–	–	2054

Other funds holding YARW

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return

AlphaCentric Advisors San Juan, Puerto Rico $118M AUM

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

EAM

Exome Asset Management New York $162M AUM 259.04% 1-Year Est. Return

PCM

Prelude Capital Management New York $1.37B AUM 71.68% 1-Year Est. Return

Federated Hermes's YARW Position: Q4 2023 in Review

Federated Hermes sold out of Yarrow Bioscience (YARW) in Q4 2023, closing a stake of 3 shares — an estimated $513 sold.

Federated Hermes first reported a position in YARW in Q3 2021 and held it in 9 quarters. The position peaked at $3K in Q3 2021. 31 funds tracked by Wall St. Rank hold YARW as of Q4 2023.

Federated Hermes reported no remaining Yarrow Bioscience position as of Q4 2023 after selling out during the quarter.
Federated Hermes sold 3 Yarrow Bioscience shares in Q4 2023, an estimated $513.
Federated Hermes first reported a position in Yarrow Bioscience in Q3 2021 and held it in 9 quarters.
Federated Hermes's Yarrow Bioscience position peaked at $3K in Q3 2021.
31 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q4 2023.

Based on Federated Hermes's 13F filing for Q4 2023, filed 31 Jan 2024.